Company Filing History:
Years Active: 2001
Title: Gabriele Bräunlich: Innovator in Medicinal Chemistry
Introduction
Gabriele Bräunlich is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating inflammatory processes. His work has led to the creation of a patent that showcases his innovative approach to drug development.
Latest Patents
Gabriele Bräunlich holds a patent for "3-Ureido-pyridofurans and -pyridothiophenes for the treatment of inflammatory processes." This patent describes a method for preparing 3-urea-pyridofurans and -pyridothiophenes by reacting appropriately substituted 3-amino-pyridofurans or -pyridothiophenes with isocyanates or isothiocyanates. The resulting compounds can serve as active ingredients in medicaments, particularly for the treatment of acute and chronic inflammatory processes. He has 1 patent to his name.
Career Highlights
Gabriele Bräunlich is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His role at Bayer has allowed him to work on cutting-edge research and development projects that aim to improve health outcomes through innovative medicinal solutions.
Collaborations
Throughout his career, Gabriele has collaborated with esteemed colleagues, including Mazen Es-Sayed and Rudiger Fischer. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Gabriele Bräunlich is a distinguished inventor whose work in medicinal chemistry has the potential to impact the treatment of inflammatory diseases significantly. His innovative contributions and collaborations highlight the importance of research in developing effective therapeutic solutions.